Four primer systems, amplifying fragments of the gene coding for the small ribosomal subunit (18s rRNA) were characterised with pure cultures of 65 medically relevant fungal species plus two mushrooms. A primer cocktail (TR1 /CAl-TR2/AF2) amplified 59 of 67 fungal species; the universal fungal primer 1 (UF1) in combination with the eukaryotic primers S3 or EUl amplified 64 and 65 of 67 fungal species, respectively. The design of an additional primer (RZY1) enabled the amplification of the missing members of the zygomycetes. The primer systems amplified all the medically relevant fungi tested. These included eight Candida spp. and seven other yeast species, 13 dermatophytes, 32 moulds (including six zygomycetes and five dimorphic fungi) and two mushrooms. Eleven controls including DNA from Schistosoma mansoni, Escherichia coli, Mycobacterium tuberculosis and man were not amplified. The oligonucleotide CA hybridised with C. albicans, C. tropicalis and C. parapsilosis; the oligonucleotide TR hybridised with the 13 dermatophytes; the oligonucleotide AF hybridised with Aspergillus fumigatus, A. Jlavus, A. terreus, A. nidulans, A. versicolor, A. tamarii, A. clavatus, A. Jischeri, but not with A. niger or A. versicolor; and the oligonucleotide HC hybridised with three varieties of Histoplasma capsulatum. These oligonucleotides did not hybridise with the other fungi nor the controls. The specificity of the newly designed primer systems was confirmed by selective amplification of fungal DNA from human lung tissue spiked with fungal biomass and from vitrectomy fluid of a patient with candida endop h t halmitis.
Introduction
Deep-seated mycoses often present with non-specific symptoms and involve a large number of different organisms. Therefore, an appropriate diagnostic procedure will require a universal primary step of fungus detection for differentiation of a fungal infection from other infective diseases. This may be accomplished by PCR with universal fungal primers. A second general method should allow the identification of the causative agent, preferably to the species level. This may be accomplished by hybridisation with probes specific for common fungal species or fungal groups such as Candida or Aspergillus. To avoid the requirement of a wide range of specific antibodies or probes, sequence analysis of the amplification products may be preferred for rare agents of mycoses. This proposed molecular approach would overcome several limitations of classical identification techniques: (1) slow growth of many relevant fungi with delayed production or lack of characteristic fruiting bodies or macroconidia; (2) the sexual reproduction cycle is unknown or lacking with many imperfect fungi; (3) special nutritional requirements of certain fungi; (4) similarity of macromorphology or micromorphology, or both, at the genus level; ( 5 ) antigenic cross-reactivity between important species and genera; and (6) possibly hazardous cultures for the health of laboratory personnel. In addition, problems originating in the availability of clinical samples and poor viability of fungal elements in smears or tissues may be overcome. There is a limited diversity of fungal growth in invasive disease. Branched hyphae with septae may be observed in tissue infected with Candida or Aspergillus spp. Distinct features, like fruiting bodies (e.g., Aspergillus heads) and characteristic conidia or spores (e.g., chlamydospores of C. alhicans), are rarely produced in vivo. All classical identification techniques require considerable periods of time spent by specialised mycologically trained personnel.
For the polymerase chain reaction (PCR)-mediated detection of fungi in clinical specimens, several primer systems, which do not cross-react with sequences of bacteria, parasites, plants, animals or man, have been described. Some are targeted to the gene coding for the small ribosomal subunit (1 8s rRNA), which consists of c. 1750 bp [l-71. Published primers have certain disadvantages, including gaps with important fungal pathogens like Cryptococcus and members of the class zygomycetes or amplification of rather large products ( 3 500 bp) complicating the amplification from formalin-fixed tissue [ 1-71. Sequences of the 18s rRNA gene are accessible for >201 fungi, including > 10 yeast species and many other filamentous fungi of medical relevance [8-121. Similar approaches have been undertaken which target the large subunit rRNA genes [ 131.
An earlier study reported the design and preliminary evaluation of fungal primer systems for 18s rDNA [6] . These quite universal fungal primer systems lacked cross-reactions with other eukaryotes, and amplified 10 representatives of the medically relevant fungal groups. However, possible gaps show up only in a large-scale evaluation.
The aims of this study were: (i) to evaluate published primers with an extended spectrum of 65 fungal pathogens and two mushrooms; (ii) to design a primer for pathogenic members of the zygomycetes, which failed to be amplified by any primer system published to date; (iii) evaluate published probes with an extended set of fungal amplicons and controls; and (iv) to show the utility of these molecular probes with human lung tissue and vitrectomy fluid. The oligonucleotides characterised in this study should enable the detection and preliminary classification of fungi in clinical specimens despite contamination with other eukaryotic cells, including human tissue, within a few days.
Materials and methods

Primers and probes
Database searches and sequence analyses were performed with the HUSAR (Heidelberg Unix Sequence Analysis Resources) computer system at the German Cancer Research Center, Heidel berg, Germany. The 18s rDNA sequences of representative fungal species, plants and animals were retrieved from the European Molecular Biology Laboratory (EMBL, Heidelberg, Germany) database. Furthermore, the sequences of 20 1 fungal species were retrieved from the database available via Internet server URL: http: /rrna.uia.ac.be/.
The sequences were aligned with a multalign program [ 141 and visually checked for homologous regions, unique to fungi. The selected primers and probes (Table 1) were custom synthesised by TIB Molbiol (Berlin, Germany).
Organisms
Sixty-five medically relevant fungal species, two mushroom species, nine eukaryotic controls, and two prokaryotic controls (Table 2) were selected for testing the specificity of the primer and probes. For testing of the primer system S 1 -RZY 1 two additional members of the zygomycetes were included, Apophysomyces elegans and Syncephalustrum racernosurn.
Sample preparation
Fungal and control DNA was extracted by microwave treatment, followed by a purification and concentration procedure with glass beads (Geneclean I1 Kit, Bio 101, USA).
Briefly, two loops of fungal biomass (yeast or mycelia) from several day-to several week-old cultures on Sabouraud's dextrose (2%) agar were suspended in 350 p l of TE buffer (Tris-HC1 10 mmol/L, pH 8.0, Na-EDTA 1 mmol/L) in 15-ml plastic tubes and subjected to five cycles, 1 min each, of microwave treatment at 200 W, with intermediate cooling on ice.
The Geneclean IT kit was used according to the manufacturer's recommendations. Briefly, 300 pl of the microwave-treated suspensions were transferred to 1.5-ml Eppendorf tubes containing 1 ml of saturated NaI and 3 ,ul of glass beads. The tubes were incubated at room temperature on a gyratory shaker at 100 rpm for 15 min, centrifuged at 17 000 g for 1 min at 4"C, and the supernate was discarded. The pellet was washed three times in 500 pl of new wash buffer (contained in the Geneclean I1 kit). The final pellet was dried under vacuum, suspended in 50 pl of water and incubated at 50°C for 5 min. The DNA was recovered in the supernate following centrifugation and kept at -20°C until used.
Human lung tissue was collected at autopsy from a patient who died from cardiac infarction. The tissue was free of contaminating fungi, as shown by culture of samples in Sabouraud's glucose broth. Lung tissue (5 g) was homogenised with 3 ml of sterile NaCl solution with a stomacher (Lab Blender 80; Seward Medical UAC House, London). Samples (200 pl) of lung homogenate were spiked with 100 p l of a serial dilution of viable C. alhicans in sterile distilled water giving final concentrations of lo8-10' ml of lung tissue homogenate.
To study the effect of formalin fixation and embedding in paraffin wax, mycelia of A . fumigutus, Penicillium marneffei, Fusariurn oxysporum and Pseudullescheriu. boydii grown for 1 week on Sabouraud's glucose (2%) agar, were fixed in formalin 4% overnight and embedded in paraffin wax. Five sections of 5 pm each were transferred into a 1.5-ml Eppendorf tube, deparaffinised with n-hexane, treated with ethanol 99.9% and subjected to the sample preparation method described above.
Finally, two samples of vitrectomy fluids from patients with endophthalmitis were examined; 3, 6 and 9 pl of the samples were subjected directly to the PCR without any pretreatment.
PCR ampl2Jication
PCR amplification was performed according to standard procedures [8] with the DNA extracted from fungi and control organisms and the following temperature cycling profile: initial denaturation at 95°C for 3 min, followed by 35 cycles of denaturation at 95°C for 1 min, annealing at 53°C for 1 min and extension at 72°C for 1 min.
Polyacrylamide gel electrophoresis and dot-blot hybridisation
For detection of the amplified fragments, 30 pl was removed from the reaction tubes and electrophoresed on a vertical polyacrylamide 5% gel with TBE buffer (0.089 M Tris, 0.089 M boric acid, 0.002 MEDTA). The gels were run at 12 V/cm for 2 h, stained with ethidium bromide in TBE for 15 min and visualised with a UV transilluminator. For dot-blotting, the DNA samples (PCR products) were heated to 95°C for 5 min, chilled immediately on ice, and one volume of 20 X SSC (3 M NaCl, 0.3 M sodium citrate) was added. The positively charged nylon membrane (HybondTM N+; Amersham Life Sciences) was pre-wetted with 10 X SSC, secured in a microfiltration apparatus (BioDot SF; BioRad Laboratories) and spotted with 2.0 pl samples of the DNA, with drying time allowed between each sample. The membrane was incubated in a denaturing solution (1.5 M NaC1, 0.5 M NaOH) for 5 min, and transferred to a filter paper wad soaked in neutralking solution (1.5 M NaCl, 0.5 M Tris-HC1. pH 7.2, 0.0001 M EDTA) for 1 min. The membrane was blot dried with filter paper and further dried in air. The DNA was fixed by baking the membrane in an oven at 80°C for 2 h. The membrane was prehybridised at 48°C for 30 min in 0.9 M NaCl, 6 mM EDTA, 90 mM Tris, SDS 1%, supplemented with yeast RNA (Boehringer, Mannheim, Germany) 1 g/L, followed by hybridisation at 43°C or 48°C overnight with 32P-labelled CA, AF, TR and HC oligonucleotides respectively in 15 ml of prehybridisation solution. Membranes were washed in a solution of 3 X SSC, SDS 5% and 10 mM sodium phosphate (pH 7.0) at 43°C or 48°C for 10 min, then in 1 X SSC, SDS 1% at 43°C or 48"C, respectively, and exposed to a scientific imaging film (X-OMAT AR, Kodak, USA) in an X-ray film cassette.
Results
Twelve oligonucleotides, which have been described previously [3, 6, 151 and the two new oligonucleotides CUFl and RZY1, were custom synthesised (TIBMolbiol, Berlin, Germany). The primers were designated Sl, S3, EUl, TR1, CA1, TR2, AF2, UF1, CUF1, RZY 1 and the 32P-labelled hybridisation oligonucleotides CA, AF, TR, and HC (Table 1) . The primers have different specificities and amplify 18s rDNA-fragments of lengths presented in Fig. 1 .
To rule out possible non-specific inhibition of the PCR reactions by constituents of the samples, control reactions with the broadly reactive primers Sl and S3 for eukaryotic 18s rDNA [I61 were performed. Under identical PCR conditions, these control primers amplified the DNA of all 67 fungi along with the DNA of nine eukaryotic control organisms, but not the DNA of the prokaryotes Escherichia coli and Mycobacterium tuberculosis (Table 2) . Seventy-six amplicons had the expected size, and two were larger than expected by c. 400 bp. These two (Exophialal Wangiella dermatitidis and Histoplasma capsulatum var. farciminosum) contained introns, proven by sequence analysis (data not shown).
In a first attempt to amplify the 18s rDNA of a larger spectrum of fungal species than described previously [ 1-51, the dermatophyte specific primer system TR1-TR2 [3] was supplemented with the candida primer CA1 and the aspergillus primer AF2.' The resulting primer cocktail (TRI /CAI -TR2/AF2) amplified the DNA of 59 fungal species and the amplicons obtained had the expected fragment lengths with the exception of H. cupsulatum var. farciminosum. This primer cocktail failed to amplify Rhodotorula, Malasseziu, Exophialal Wangiella, Phialophora, Rhizopus, Syncephalastrum and the mushrooms. With the exception of the plants Physcomitrella, Abies and Brassica, the controls were either not amplified or produced amplicons of clearly different sizes (Table 2) . Polyacrylamide gels demonstrating the clearly different sizes of the E. coli amplicons have been published previously [6] .
The primer system UF1-S3 was designed to reduce the number of primers involved, to further increase the number of fungal species covered and to reduce the number of cross-reacting controls. It amplified the DNA of 59 representative fungal species and the amplicons obtained had the expected fragment lengths. The zygomycetes Rhizopus, Rhizomucor and Absidia were not amplified. With the exception of the prokaryote E. coli, which produced an amplicon of a clearly different size, and the plants Physcomitrella and Brassica, which cross-reacted, none of the controls was amplified ( Table 2 ).
The reverse primer EU1 was designed to enable the Kappe et al.
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Kappe et al. amplification of shorter products in combination with Sl or with UF1, which may be an advantage for certain applications, e.g., PCR amplification from paraffinembedded tissues [ 171. The amplification spectrum and the specificity of the primer system UFl-EUl was similar to that of UFl-S3, except that the former also weakly amplified Rhizomucor and cross-reacted with Abies lasiocarpa (Table 2) . Expectedly, the presence of introns in the 18s rDNA of H. capsulatum var. farciminosum and E./W dermatitidis was not revealed in the UF1-EU1 amplicons, as the intron insertion positions lie outside the amplified regions. To cover the complete spectrum of the zygomycetes, the reverse primer RZY 1 was designed, starting at position 3 15, at the end of the variable region 2 (V2) near the position of UFl and the reverse primer CUFl (complement of UFl) (Table 1, Fig. 1 ). The combination of RZYl and Sl enabled the amplification of 230-bp products of eight members of the zygomycetes (Abs. corymbifera, Apo. elegans, Mucor circinelloides, Rhizomucor pusillus, Rhizopus oryzae, Saksenaea vasiformis, Cunninghamella bertholletiae and Syn. racemosum), and there was no amplification of any of the other 72 organisms presented in Table 2 .
The fungal origin of the amplification products as well as a preliminary taxonomic classification were revealed by hybridisation. The oligonucleotide CA reacted with the amplicons from C. albicans, C. tropicalis and C. parapsilosis, but not with the other hngi nor the controls (Fig. 2b) . The oligonucleotide AF reacted with the amplicons from A. fumigatus, A .
J-lavus, A. terreus, A. versicolor (weak), A. tamarii, A. clavatus and A .
Jischeri, but not with the other fungi or the controls (Fig. 2c) . The oligonucleotide TR reacted with the amplicons from all 13 dermatophytes tested (Fig. 2d) , including Microsporum ferrugineum (not shown), but not with those of the other fungi or the controls. The oligonucleotide HC reacted with the amplicons from H. capsulatum var. capsulatum, H. capsulatum var. duboisii and H. capsulatum var. farciminosum, but not with those of other fungi or the controls (Fig. 2e) .
To prove the suitability of the primer systems for amplification of fungal DNA from clinical samples, human lung tissue was spiked with C. albicans and subjected to sample preparation and PCR. Selective amplification of C. albicans DNA was possible with the primers S1-CUF1 with a level of sensitivity of lo6 C. albicans blastospores/ml of homogenised lung tissue.
Formalin fixation and paraffin embedding of fungal mycelia did not prevent amplification of small products. Positive results were obtained with A.
fumigatus, I? rnarneff, E oxysporum and I? boydii with the primer pairs UF1-EU1 (138-bp product) and Sl-CUF1 (178-bp product) in three of three experiments and four of four experiments, respectively. Table 2 . Panels b-e represent results of hybridisations with the probes CA, AF, TR and HC, respectively. The 69 PCR products were amplified by the primer systems UFl-S3 or Sl-S3. The membrane was separately hybridised with each probe, i.e., autoradiographed and stripped after each hybridisation.
The results of assay of the vitrectomy fluids are presented in Fig. 3 . The patient with candida endophthalmitis was clearly positive, whereas the other patient with endophthalmitis of unknown aetiology and the controls were negative.
Discussion
As there is no 18s rDNA sequence variation within a given species (no strain variation) and results matched 1 2 3 4 S 6 7 0 9 1 0 1 1 V2CA those expected from published sequences [ 121, there was no need to study multiple strains of each species.
The primer systems TRl /CA 1 -TR2/AF2 and UF 1 -S3 amplified DNA from 59 and 64 representatives of the medically relevant fungal groups, respectively (yeasts, moulds, dermatophytes and dimorphic fungi), but not the DNA of other eukaryotic organisms, including the parasite Schistosoma mansoni, the yeast-like alga Pro. zopfii and man ( Table 2 ). The failure to react with controls was not due to the lack of target DNA nor to an inhibition of the PCR, because broadly reactive eukaryotic primers readily amplified all samples tested except the prokaryotes E. coli and M. tuberculosis (Table 2 ). The primer UFl failed to amplify some members of the zygomycetes, including Rhizopus oryzue and Abs. corymbifera, and was not a truly 'universal fungal' primer in this study. Weak amplification or complete failure to amplify a fungal species may be explained by the number and the position of nucleotide mismatches of the primers to the fungal DNA. The failure of UF1 to amplify some of the zygomycetes is partially explained by sequence information on the 18s rDNA of Rhizomucor pusillus, Rhizopus oryzae and Abs. corymbifera (personal communication, K. O'Donnell, and own unpublished data), which differ considerably from 18s rDNA sequences of basidiomycetes and ascomycetes. Therefore, for a complete amplification of the order Mucorales, with the 18s rDNA, the additional oligonucleotide FUY 1, was designed, which is homologous for the eight zygomycetes studied. As its position on the 18s rDNA is very close to UF1 and CUFl, a single truly universal fungal PCR may be developed, which could work with one broadly reactive forward primer at the beginning of the 18s rDNA and a combination of CUFl and RZY1 (at the end of the variable region V2, around position 280). Advantages of this asymmetrical PCR would include a short amplification product (c. 200 bp), which contains the variable region V2 for specification.
Weak hybridisation or complete failure of a probe to hybridise with a fungal amplicon is explained by at least one nucleotide mismatch of the hybridisation oligonucleotide to the corresponding sequence of the fungal amplicon. Published fungal sequences [9-1 I] allow the following reasoning. The CA probe perfectly fits C. albicans, C. tropicalis and C. parapsilosis; however, it contains mismatches for C. krusei (n = lo), C. glabrata (n = 6 ) , C. kefir (n = 6), C. pelliculosa (n = 7), C. lipolytica (n = 12). The AF probe perfectly fits A. fumigatus, A. Jaws, A. terreus, A. tamarii and N. (A.) fischeri; however, it contains mismatches for A. niger (n = 1) and A. nidulans (n = 3). The TR probe perfectly fits all dermatophytes, but it contains mismatches for all other fungi. The HC probe perfectly fits the three Histoplasma varieties, but contains mismatches for all other fungi. For identification of fungal amplification products that fail to hybridise with the probes mentioned, additional probes may be designed. However, direct sequence analysis is recommended for rare agents of mycotic infections.
The 18s rRNA gene was used for this study, because of the large number of known sequence [9-1 I] and the favourable relationship of conserved and variable regions (Vl-V9, Fig. l) , which allow the design of suitable multipurpose oligonucleotides.
Other primer systems within the gene coding for the 18s rRNA have been described as fungus-specific [ 1, 2, 4, 5, 71. However, these primers, which have been characterised with a limited number of fungi, failed to amplify several species of medically important genera including Alternaria, Cryptococcus, Mucor and Sporothrix, because of three or more mismatches in each case.
PCR-based detection and identification of fungi has been described for several types of clinical specimens including samples from the respiratory tract [ 18-2 11 and serum or blood [2, 7, [22] [23] [24] [25] . Claimed sensitivities of 1 cfu of C. albicans/ml of blood [2, 71 have not been confirmed. Sample preparation remains a serious problem, limiting the sensitivity of the assays.
Identification of fungi in paraffin-embedded tissue has been achieved by immunohistochemistry [26] , by insitu hybridisation [27] and by sequencing of ribosomal DNA [28] . Immunohistochemistry and in-situ hybridisation require specific probes and do not lead to species identification. Formaldehyde fixation appears to modify human and viral DNA [ 17, 281. Williams et al. [28] amplified candida DNA fragments (218 bp) from paraffin wax-embedded tissue. The preliminary experiments described in the present study indicate that selective amplification of fungal DNA from human lung tissue spiked with C. albicans is possible with short products (138 and 178 bp) with a sensitivity of lo6 C. albicans cells/ml of homogenised lung tissue. Furthermore, amplification was still possible after formalin fixation and embedding in paraffin of important pathogens, which are hard to distinguish by histology. Finally, the results with the vitrectomy fluids show that the primer systems evaluated in this study work with clinical samples. The simplified strategy for clinical samples will include PCR amplification by broadly reactive fungal primers followed by hybridisation with probes for the most common fungal pathogens, i.e. Candida spp. (V2CA specific for C. albicans or C. parapsilosis) or Aspergillus spp. (V2AF specific for moulds, but lacking cross-reactions with yeasts). Amplification products of rare fungal species should be sequenced for species identification rather than probing with a huge set of species-specific primers, which could never be exhaustive.
